Poop pills could tame IBD in Drug-Resistant patients
NCT ID NCT07149441
First seen Sep 30, 2025 · Last updated Jun 22, 2026 · Updated 41 times
Summary
This study tests whether fecal microbiota transplant (FMT) capsules, taken alongside standard biologic therapy, can improve symptoms and gut health in people with inflammatory bowel disease (Crohn's or ulcerative colitis). 94 patients who did not get better with biologics alone will receive either FMT capsules plus biologics or biologics alone. Researchers will track remission rates and safety over 52 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (CROHN'S DISEASE AND ULCERATIVE COLITIS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fecal microbiota transplant capsules
What this could lead to
If it works, this could offer a new way to improve symptoms and gut health for people with inflammatory bowel disease who haven't responded to standard treatments.
What could go wrong
This is a small, early-stage study with no placebo group, so results may not be conclusive. The treatment involves transplanting donor stool, which carries unknown long-term risks.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.